Nicholas Coriasso, DO
Interventional Cardiology · Petoskey, MINPI 1194257709
Payments from drug & device makers
Across 173 payments — averaging $40.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$2K
- Abbott$1K
- Inari Medical, Inc.$435
- Penumbra, Inc.$388
- Boston Scientific$386
- Amgen$372
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$90013%
- Food & beverage$6,01785%
- Education$1472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 26 | $1,674 |
| Abbott | 34 | $1,326 |
| Inari Medical, Inc. | 18 | $435 |
| Penumbra, Inc. | 6 | $388 |
| Boston Scientific | 12 | $386 |
| Amgen | 5 | $372 |
| Johnson & Johnson | 4 | $359 |
| Shockwave Medical, Inc | 13 | $318 |
| Cardiva Medical, Inc. | 9 | $300 |
| Esperion Therapeutics, Inc. | 2 | $240 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $227 |
| Medtronic | 2 | $161 |
| Chiesi USA, Inc. | 7 | $137 |
| Boehringer Ingelheim | 1 | $116 |
| Philips North America LLC | 6 | $105 |
| AstraZeneca | 2 | $94 |
| Teleflex LLC | 4 | $73 |
| Novartis | 3 | $69 |
| Pfizer | 4 | $68 |
| Cordis US CORP. | 4 | $66 |
| Terumo Medical Corporation | 2 | $44 |
| Impulse Dynamics (USA) Inc. | 1 | $41 |
| Asahi Intecc USA, Inc. | 1 | $32 |
| Edwards Lifesciences | 1 | $18 |
| Biosense Webster, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,046
- Repatha$346
- XARELTO$338
- OPTIS$282
- PRESSUREWIRE$278
- Indigo System$256
- NEXLIZET$240
- NEXLETOL$240
- COREVALVE EVOLUT R$145
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$145
- FLOWTRIEVER CATHETER, S$136
- CT THROMBECTOMY SYSTEM KIT$136
- JARDIANCE$116
- AMPLATZER TALISMAN$114
- WATCHMAN Access System$101
How this compares
$7,063 in reported general payments places this provider in the 40th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 46 | $1,029 |
| Rosuvastatin Calcium | 20 | $551 |
| Metoprolol Succinate | 20 | $372 |
| Atorvastatin Calcium | 15 | $239 |
| Losartan Potassium | 14 | $140 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Petoskey
- Jason RicciPetoskey$1.1M
- Harry ColferPetoskey$940K
- Louis CannonPetoskey$190K
- Amir KakiDetroit$2.3M
- William MerhiGrand Rapids$2M
- Shukri DavidSouthfield$1.6M
- Qaiser ShafiqSouthgate$1.3M
- Marcel ZughaibSouthfield$1.2M
- Khaldoon AlaswadDetroit$1.1M
- Paul GrossmanAnn Arbor$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.